GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » EV-to-EBITDA

Cantourage Group SE (XTER:HIGH) EV-to-EBITDA : 0.00 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cantourage Group SE's enterprise value is €0.00 Mil. Cantourage Group SE's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €0.06 Mil. Therefore, Cantourage Group SE's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Cantourage Group SE's EV-to-EBITDA or its related term are showing as below:

XTER:HIGH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -116.59   Med: 0   Max: 0
Current: -20.58

XTER:HIGH's EV-to-EBITDA is ranked worse than
100% of 715 companies
in the Drug Manufacturers industry
Industry Median: 14.42 vs XTER:HIGH: -20.58

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Cantourage Group SE's stock price is €7.20. Cantourage Group SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.000. Therefore, Cantourage Group SE's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cantourage Group SE EV-to-EBITDA Historical Data

The historical data trend for Cantourage Group SE's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE EV-to-EBITDA Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
EV-to-EBITDA Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cantourage Group SE's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's EV-to-EBITDA falls into.



Cantourage Group SE EV-to-EBITDA Calculation

Cantourage Group SE's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/0.057
=0.00

Cantourage Group SE's current Enterprise Value is €0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cantourage Group SE's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE  (XTER:HIGH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cantourage Group SE's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.20/0.000
=N/A

Cantourage Group SE's share price for today is €7.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cantourage Group SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cantourage Group SE EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines

No Headlines